X hits on this document

37 views

0 shares

0 downloads

0 comments

11 / 12

B. Amsden

CHEE 440

NEW DRUG SUBMISSION

NDS in Canada, ND Application in US

contents

all the preclinical and clinical data

includes pharmacokinetics and bioavailability, discussion of risk and benefits, complete proposed product labeling

HPFB and FDA rule on acceptability (2-4 years)

Document info
Document views37
Page views37
Page last viewedFri Jan 20 02:40:19 UTC 2017
Pages12
Paragraphs147
Words546

Comments